SGYP

Synergy Pharmaceuticals, Inc Common Stock
SGYP

Overview Fund Activity
Delisted

SGYP was delisted on the 7th of March, 2019.

Back to rankings

147 hedge funds and large institutions have $202M invested in Synergy Pharmaceuticals, Inc Common Stock in 2018 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 39 increasing their positions, 44 reducing their positions, and 27 closing their positions.

Holders
147
Holders Change
-2
Holders Change %
-1.34%
% of All Funds
3.37%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
26
Increased
39
Reduced
44
Closed
27
Calls
$4.26M
Puts
$7.36M
Net Calls
-$3.1M
Net Calls Change
+$1.11M

Top Buyers

1
NCM
1
Nantahala Capital Management
Connecticut
$21.2M
2
CH
2
CVI Holdings
Delaware
$3.24M
3
Barclays
3
Barclays
United Kingdom
$1.11M
4
Millennium Management
4
Millennium Management
New York
$923K
5
Morgan Stanley
5
Morgan Stanley
New York
$3.18M

Top Sellers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$3.52M
2
TI
2
Truepoint Inc
Ohio
$20K
3
PC
3
Paulson & Co
New York
$0
4
PAMU
4
Pictet Asset Management (UK)
United Kingdom
$0
5
Citigroup
5
Citigroup
New York
$1.29M
Name Market Value Shares Shares
Change 		Shares
Change %
PWM
176
Perigon Wealth Management
California
$0 100 +100 New
RWP
177
RWA Wealth Partners
Massachusetts
$0 100 +100 New
TC
178
Trilogy Capital
California
$0 200 +200 New
4 5 6 7
8